is 0.25 mg semaglutide effective of Wegovy (semaglutide) every 2 weeks an maintenance dose? Semaglutide - Uses | Limitations

Our study reports a link between decreased GSH status and impaired VD metabolism genes in the liver

GLP-1 receptor agonistssuch as semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound)work by mimicking hormones that regulate blood sugar, appetite, and digestion

Acknowledgements The authors would like to thank Christine Wogan, MS, ELS, of MD Anderson Cancer Centers Division of Radiation Oncology for editorial assistance

In a pivotal year-long trial, individuals undergoing semaglutide treatment experienced an average weight loss of 14.9%, with approximately one-third achieving an impressive weight reduction exceeding 20% (PubMed)

Pavlovic N, Tcheugui JE, &Ndumele CE